These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 20298399)
1. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial. Ulrik CS; Claudius BK; Tamm M; Harving H; Siersted HC; Backer V; Hellquist B; Dahl R; Høgholm A; Jøhnk IK Clin Respir J; 2009 Jul; 3(3):161-8. PubMed ID: 20298399 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991 [TBL] [Abstract][Full Text] [Related]
3. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [TBL] [Abstract][Full Text] [Related]
4. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023). Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M; Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834 [TBL] [Abstract][Full Text] [Related]
5. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437 [TBL] [Abstract][Full Text] [Related]
6. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212 [TBL] [Abstract][Full Text] [Related]
7. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Fardon T; Haggart K; Lee DK; Lipworth BJ Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217 [TBL] [Abstract][Full Text] [Related]
8. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; Pétavy F; James M Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498 [TBL] [Abstract][Full Text] [Related]
9. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891 [TBL] [Abstract][Full Text] [Related]
10. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma? Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683 [TBL] [Abstract][Full Text] [Related]
11. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate. Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of the combination of fluticasone propionate and salmeterol in patients with moderate persistent asthma within a "real-life" setting. Trautmann M; Banik N; Tews JT; Jörres RA; Nowak D Eur J Med Res; 2007 Jun; 12(6):255-63. PubMed ID: 17666315 [TBL] [Abstract][Full Text] [Related]
13. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma. Delea TE; Hagiwara M; Stanford RH; Stempel DA Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids. You-Ning L; Humphries M; Du X; Wang L; Jiang J Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199 [TBL] [Abstract][Full Text] [Related]
15. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD. Schermer TR; Albers JM; Verblackt HW; Costongs RJ; Westers P Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178 [TBL] [Abstract][Full Text] [Related]